DLBS1033 for the Treatment of Acute Ischemic Stroke

Summary

This is a prospective, randomized, double-blind, and controlled clinical study to investigate the effects of DLBS1033 in conjunction with standard therapy compared to standard therapy alone in acute ischemic stroke patients.

Timeline

Start

2014-10

Primary completion

2017-02

Completion

2017-04

Drugs

Indications